Sample | Title | Value | Rank |
GSM1256958 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 2 | 1049.63 | 97 |
GSM1256959 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 4 | 1053.38 | 97 |
GSM1256960 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 7 | 1288.85 | 97 |
GSM1256961 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 8 | 1055.68 | 97 |
GSM1256962 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 9 | 1161.46 | 97 |
GSM1256963 | SLE-patients; Group 1: CD4 T lymphocytes; active SLE 12 | 1057.04 | 97 |
GSM1256972 | Yellow fever vaccinated NDs; Group 4: CD4 T lymphocytes; ND 54 before YFV | 647.054 | 95 |
GSM1256976 | Yellow fever vaccinated NDs; Group 5: CD4 T lymphocytes; ND 54 seven days after YFV | 883.897 | 96 |
GSM1256973 | Yellow fever vaccinated NDs; Group 4: CD4 T lymphocytes; ND 55 before YFV | 656.922 | 95 |
GSM1256977 | Yellow fever vaccinated NDs; Group 5: CD4 T lymphocytes; ND 55 seven days after YFV | 687.55 | 95 |
GSM1256974 | Yellow fever vaccinated NDs; Group 4: CD4 T lymphocytes; ND 56 before YFV | 951.45 | 97 |
GSM1256978 | Yellow fever vaccinated NDs; Group 5: CD4 T lymphocytes; ND 56 seven days after YFV | 1039.29 | 97 |
GSM1256975 | Yellow fever vaccinated NDs; Group 4: CD4 T lymphocytes; ND 57 before YFV | 711.706 | 95 |
GSM1256979 | Yellow fever vaccinated NDs; Group 5: CD4 T lymphocytes; ND 57 seven days after YFV | 874.993 | 96 |